Related Resources
Gabby Migliara
Gabby Migliara is a director of Public Affairs at PhRMA focusing on internal communications and PhRMA’s digital presence, including maintaining this website and executive social presence. She previously worked with the U.S. Census Bureau on marketing and communications for the 2020 Census campaign. Outside the office, Gabby enjoys trying new restaurants, hanging with her cat and exploring D.C. neighborhoods.
Medicaid by the numbers
July 30, 2024
What’s the 340B program like in your state?
February 7, 2024
What they are saying: Florida Drug Importation Program is Unfeasible and Dangerous
January 17, 2024
Florida’s importation plan puts patients in danger
January 5, 2024
Manufacturers provided $42 billion in Medicaid discounts in 2021 alone
August 10, 2023
CMS should rethink proposed changes to the Medicaid Drug Rebate Program | PhRMA
August 1, 2023
Nonprofit hospitals fall short on community benefit, studies show
April 24, 2023
CMS coverage policy is detrimental to Alzheimer’s patients
April 4, 2023
What they are saying: Nonprofit hospitals are gaming the system at the expense of patients
February 21, 2023
CMS coverage policies restrict patient access to important treatment options for Alzheimer’s disease
September 1, 2022
Celebrating Medicare’s 57th anniversary
August 2, 2022
New research shows competition driven by biosimilars helps control costs in Part B
July 19, 2022
ICYMI: Antimicrobial resistance spotlighted as growing public health threat
July 6, 2022
Why drug importation is bad for Americans
May 12, 2022
ICYMI: New resource catalogs biopharmaceutical industry lessons learned from COVID-19
April 28, 2022
Three charts show how the Medicare Part D program could be improved to work better for seniors and people with disabilities
April 27, 2022
Part D 101: Three charts show how the program provides comprehensive prescription drug coverage
April 26, 2022
New analysis confirms hospitals markup prices for oncology therapies
April 21, 2022
Veterans Affairs 101: Three charts show how the VA system differs from Medicare
March 11, 2022
ICYMI: New study confirms policies like H.R. 3 could significantly reduce drug development
October 18, 2021
To drive up profits, hospitals continue unnecessary medicine mark-ups, burdening patients, employers and health care system
October 14, 2021
PhRMA releases 2021 industry profile
September 20, 2021
What they’re saying: Patient advocates want to protect Medicare from government interference
August 24, 2021
Celebrating Medicare’s 56th anniversary
July 30, 2021
Government “negotiation” could have devastating consequences for Medicare enrollees
July 23, 2021
Protecting Medicare from government interference
July 21, 2021
Medicare “negotiation” proposals threaten Americans’ access to medicines
June 30, 2021
Americans 12 years of age and older are eligible for COVID-19 vaccines
June 17, 2021
The ABCs (and Ds) of Medicare
May 13, 2021
H.R. 3 threatens access to medicines, future innovation and American jobs
May 4, 2021
Insurers shift medicine costs to patients with severe chronic illnesses
February 1, 2021
The new Administration should reconsider a recent HHS rule that could negatively impact patient access and affordability
January 27, 2021
Accumulator adjustment programs lead to surprise out-of-pocket costs and nonadherence, analysis finds
November 19, 2020
Hospital and outpatient care are biggest drivers of health care spending differences between the United States and others
October 22, 2020
Study finds biopharmaceutical innovation is responsible for 35% of the increase in life expectancy from 1990 to 2015
October 21, 2020
Survey found insurance premiums grew faster than inflation in 2020
October 20, 2020
Manufacturer cost-sharing assistance programs can save chronically ill patients hundreds to thousands of dollars annually
August 19, 2020
Commercial health plans have increased patients’ out-of-pocket costs by over 50% in some therapeutic areas
August 12, 2020
Commercial health plans transition from copays to coinsurance and deductibles has increased patient out-of-pocket costs
August 6, 2020
New data show commercially insured patients face increasingly high cost sharing for brand medicines
July 30, 2020
Payers subject 80% of new RA and MS patients to utilization management restrictions
July 22, 2020
Study finds the pharmaceutical industry retains a smaller share of revenue than research-intensive industries
July 14, 2020
ICYMI: Pharmacy benefit managers increasingly exclude medicines from formularies, restricting patient access
June 1, 2020
ICYMI: America’s biopharmaceutical companies are working 'around the clock' to beat coronavirus
April 1, 2020